MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-21-0026135
Aelmar Pharmaceutical Private Limited
Aelmar Pharmaceutical Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.6 Lakh
▲ 14% YoY
Net profit · FY 2025
₹37,000
Net margin 3.5%
EBITDA · FY 2025
₹68,000
EBITDA margin 6.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Aelmar Pharmaceutical Private Limited
Data last updated:
Aelmar Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74990TG2019PTC131714. Its GSTIN is 36AASCA1149B1ZV (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Kalyanrao Patil and Abdul Rahil Quadeer Abdul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 9 – 698/1 – 4 Flat No – 405 B Block 4th Floor Naik Prudvi Golden Towers, Hyderabad, Telangana, India – 500044.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.6 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹37,000 (net margin 3.5%) and EBITDA of ₹68,000 (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 60% over five years.
Aelmar Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-21-0026135).
Company details
CIN U74990TG2019PTC131714
Registration Number 131714
Incorporation Date 29 March 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-21-0026135
Recognitions & Rankings of Aelmar Pharmaceutical
Contact details
Aelmar Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address1 – 9 – 698/1 – 4 Flat No – 405 B Block 4th Floor Naik Prudvi Golden Towers, Hyderabad, Telangana, India – 500044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aelmar Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Aelmar Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aelmar Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aelmar Pharmaceutical Private Limited, buy the company report.
Financials of Aelmar Pharmaceutical Private Limited
FY 2025 filings availableAelmar Pharmaceutical Private Limited reported revenue of ₹10.6 Lakh (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹10.6 Lakh ▲ 14%
Net profit · FY 2025
₹37,000 margin 3.5%
EBITDA · FY 2025
₹68,000 margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 8%
5 years · compounded
▲ 60%
EBITDA CAGR growth
1 year
▲ 116%
3 years · compounded
▼ 8%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 60% over five years, including 14% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aelmar Pharmaceutical Private Limited, buy the company report.
Board of directors of Aelmar Pharmaceutical Private Limited
Aelmar Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Kalyanrao Patil | Director | 29 Mar 2019 | 7 Years 7 Months | Current |
| Abdul Rahil Quadeer Abdul | Director | 29 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Aelmar Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bhavani Polymers Private Limited | ₹10.61 Lakh (FY 2025) | -76.0% | Bangalore, Karnataka, India | |||
| Makrana Marbles (India) Pvt Ltd. | ₹10.6 Lakh (FY 2024) | -9.0% | Kolkata, West Bengal, India | |||
| Homeline Electronics Private Limited | ₹10.6 Lakh (FY 2025) | 28.0% | Wynad, Kerala, India | |||
| Karmodi Unchada Talang Farmer Producer Company Limited | ₹10.6 Lakh (FY 2025) | -67.0% | Hadgaon, Maharashtra, India | |||
| Azure Biz Consultants Private Limited | ₹10.6 Lakh (FY 2025) | -77.0% | New Delhi, Delhi, India | |||
| Aelmar Pharmaceutical Private Limitedthis company | ₹10.6 Lakh (FY 2025) | ₹37,000 | 3.5% | 14.0% | Hyderabad, Telangana, India | |
| Bloomcom Private Limited | ₹10.6 Lakh (FY 2024) | 3152.0% | Chhindwara, Madhya Pradesh, India | |||
| Supermax Agro India Limited | ₹10.6 Lakh (FY 2019) | Gaya, Bihar, India | ||||
| Krushakheet Organic Farmer Producer Company Limited | ₹10.6 Lakh (FY 2024) | 106.0% | Bhandara, Maharashtra, India | |||
| Amar Tyres Pvt Ltd | ₹10.6 Lakh (FY 2025) | 0.0% | Chandigarh, India | |||
| Deevachi Aquatic Products and Services Private Limited | ₹10.6 Lakh (FY 2022) | Kashipur, Uttarakhand, India |
To see the full peer comparison of Aelmar Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aelmar Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aelmar Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aelmar Pharmaceutical has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AASCA1149B1ZV | Telangana | Active | 04 Jan 2020 |
| 27AASCA1149B1ZU | Maharashtra | Active | 11 Jan 2020 |
To see the full GST registrations and return filing status of Aelmar Pharmaceutical Private Limited, buy the company report.
Recent activity
Aelmar Pharmaceutical Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Salman Siddiqui Khan ceased to be Director on 10 Feb 2020.
AGM
Aelmar Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aelmar Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Salman Siddiqui Khan ceased to be Director.
Appointed
Abdul Rahil Quadeer Abdul was appointed as Director.
Appointed
Aditya Kalyanrao Patil was appointed as Director.
Incorporation
29 Mar 2019
Aelmar Pharmaceutical Private Limited was registered on 29 Mar 2019 with Roc Hyderabad & aged 7 years 7 months as per MCA records.
Frequently asked questions
Aelmar Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 March 2019 (7+ years old) and is registered under CIN U74990TG2019PTC131714.
Aelmar Pharmaceutical has 2 current directors:
- Aditya Kalyanrao Patil - Director
- Abdul Rahil Quadeer Abdul - Director
The latest financial statements of Aelmar Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Aelmar Pharmaceutical is 36AASCA1149B1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AASCA1149B1ZU (Maharashtra).
The CIN (Corporate Identification Number) of Aelmar Pharmaceutical is U74990TG2019PTC131714. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aelmar Pharmaceutical was incorporated on 29 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aelmar Pharmaceutical by revenue are Bhavani Polymers Private Limited, Makrana Marbles (India) Pvt Ltd, Homeline Electronics Private Limited, Karmodi Unchada Talang Farmer Producer Company Limited, Azure Biz Consultants Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Salman Siddiqui Khan ceased to be Director on 10 Feb 2020. Abdul Rahil Quadeer Abdul was appointed as Director on 29 Mar 2019. Aditya Kalyanrao Patil was appointed as Director on 29 Mar 2019.
Yes, Aelmar Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-21-0026135).
The registered office of Aelmar Pharmaceutical is at 1 – 9 – 6981 – 4 Flat No – 405 B Block 4th Floor Naik Prudvi Golden Towers, Hyderabad, Telangana, India – 500044.
Aelmar Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.